Hilda F. Scharen-Guivel - Oct 14, 2024 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Director
Signature
/s/ Hilda F. Scharen-Guivel
Stock symbol
IRMD
Transactions as of
Oct 14, 2024
Transactions value $
$0
Form type
4
Date filed
10/15/2024, 05:45 PM
Previous filing
Dec 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +1.77K +100.06% 3.53K Oct 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -1.77K -50% $0.00 1.77K Oct 14, 2024 Common Stock 1.77K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On October 14, 2022, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in three equal annual installments beginning on October 14, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.